Pretreatment Resistance to Integrase Inhibitors in the Swiss HIV Cohort Study From 1995 to 2025
Tom Loosli, Marco Labarile, Nanina Anderegg, Paul Frischknecht et autres
0 citationsOpen Forum Infectious Diseases
Nuri Han
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
9Publications signalées
46Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
HIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHIV Research and TreatmentBiochemical and Molecular ResearchTuberculosis Research and Epidemiology
Publications récentes
Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study
Nuri Han, Tom Loosli, Mamatha Sauermann, İpek Çelikağ et autres
0 citationsJournal of Antimicrobial Chemotherapy
Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study.
Nuri Han, Tom Loosli, Mamatha Sauermann, İpek Çelikağ et autres
0 citationsOpen Access CRIS of the University of Bern
Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study
Nuri Han, Tom Loosli, Mamatha Sauermann, İpek Çelikağ et autres
0 citationsZurich Open Repository and Archive (University of Zurich)
The effect of long-acting cabotegravir and rilpivirine treatment on drug resistance in South Africa: a modelling study
Nuri Han, Tom Loosli, Nanina Anderegg, Anthony Hauser et autres
3 citationsThe Lancet Global Health
Novel integrase mutations linked to genotypic DTG resistance in non-B HIV-1 strains from African participants: The DTG RESIST study
Nuri Han, Tom Loosli, Mamatha Sauermann, İpek Çelikağ et autres
1 citationmedRxiv
Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study
Tom Loosli, Carolyn Bolton‐Moore, Lydia Buzaalirwa, Helen Byakwaga et autres
14 citationsClinical Infectious Diseases
Predicted dolutegravir resistance in people living with HIV in South Africa during 2020–35: a modelling study
Tom Loosli, Nuri Han, Anthony Hauser, Johannes Josi et autres
27 citationsThe Lancet Global Health
Predicting emergent Dolutegravir resistance in South Africa: A modelling study
Tom Loosli, Anthony Hauser, Johannes Josi, Nuri Han et autres
1 citationmedRxiv
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.